SPOTLIGHT -
Database Lock in Trial for New At-Home Treatment of Agitation in Bipolar Disorders and Schizophrenia
BioXcel Therapeutics advances BXCL501 for at-home treatment of agitation in bipolar disorders and schizophrenia, aiming for FDA approval by 2026.
The Current Legal and Research Status on AI and Psychotherapy
According to a new law, humans are essential for appreciating nonverbal information and exercising ethical priorities.
Beyond Representation: Rethinking Emotional Asymmetry in Psychiatric Diversity Models
Psychiatry confronts emotional asymmetry, revealing how race and privilege shape emotional expression and affective labor in clinical settings.
Top 3 Studies on Athletes’ Mental Health from Around the Globe: Insights from the Second Quarter of 2025
Explore the latest research on athlete mental health, highlighting concussion recovery, anti-doping stress, and the protective role of competitive sports.
Optimizing Cognition and Functioning Before Evaluating Capacity
Understanding decisional capacity is crucial for effective patient care, emphasizing the need for tailored assessments and support to enhance autonomy.
A Yale Medical School Student Research Project on Therapeutic Communities 55 Years Later
Explore the lasting impact of therapeutic communities on mental health and addiction recovery, highlighting innovative research and community-building strategies.
More Than Diverse: Race as an Insufficient Proxy of American Historic Lived Expertise
An expert shares the importance of lived expertise in addressing health care inequities and fostering a deeper understanding of diversity in medical practices.
Maternal Health Is Fetal Health: A Response to the FDA's SSRI Panel Discussion
Untreated maternal mental health issues during pregnancy pose significant risks. Informed discussions on medication are crucial for mother and baby's well-being.
Far More Than Diversity: What the Field of Medicine Needs
The August Special Report emphasizes the urgent need for action beyond diversity in psychiatry, addressing systemic racism's profound impact on Black mental health.
Borderline Personality Disorder Without DBT? Absolutely.
Discover effective strategies for treating borderline personality disorder without intensive therapy, focusing on empowerment, structure, and human connection.
Hepatitis-C Virus Found to Be Associated With Schizophrenia and Bipolar Disorder
FDA Grants Fast Track Designation to Pemvidutide for Treatment of Alcohol Use Disorder
Altimmune's pemvidutide gains FDA Fast Track designation for alcohol use disorder.
The Terrible Narcissistic Triad: Addressing Hubris, Humiliation, and Revenge in War and Peace
H. Steven Moffic, MD, examines the psychological dynamics of hubris, humiliation, and revenge in global conflicts.
Optimizing Narcolepsy Management: A Clinical Update
Explore effective strategies for managing narcolepsy, including personalized treatment plans, medication options, and lifestyle interventions for improved patient outcomes.
How Our Past Trauma Drives Our Brain’s Response to New Stress
New research reveals how past trauma influences brain responses to stress, highlighting the importance of neural connectivity in mental health and coping strategies.
Risk Factors for Catatonia Relapse in Psychotic and Affective Disorders
Nearly half of catatonia patients relapse within two years, highlighting the need for effective long-term management strategies and potential benefits of antipsychotics.
BXCL501 for Agitation Associated With Bipolar Disorders or Schizophrenia: Positive Pre-sNDA Meeting With FDA
BioXcel Therapeutics advances BXCL501 for outpatient treatment of agitation in bipolar disorder and schizophrenia, receiving positive FDA feedback in its pre-sNDA meeting discussion.
A (Taylor) Swift Model Tailored for Relationships
Explore the intersection of Taylor Swift's music, relationships, and their impact on mental well-being in today's society.
FDA Approves Tonmya, First Fibromyalgia Medication in 15 Years
FDA approves Tonmya, a groundbreaking fibromyalgia treatment, offering hope for pain relief after 15 years without new options.
Cognitive Effects of Antidepressant Pharmacotherapy in Late-Life Depression
Antidepressant treatment for late-life depression enhances cognitive functions like memory and learning, linking symptom relief to cognitive improvement.
Preliminary Report on Chatbot Iatrogenic Dangers
AI chatbots pose significant mental health risks, often exacerbating issues like suicide, self-harm, and delusions, highlighting urgent regulatory needs.
We Will Survive: The Arts, Psychiatry, and the Kennedy Center
What are the cultural implications of President Trump's Kennedy Center Honors selections?
Yes, Psychotherapy Training During Residency Is an Essential Part of a Humanistic Psychiatry
Psychodynamically-informed pharmacotherapy is much more than “prescribing.”
Save the Children, Physically and Psychologically
Current crises threaten children's health and mental well-being globally, highlighting the urgent need for action and support from psychiatry and society.
Huntington Disease: Recognizing Neuropsychiatric Symptoms
The complexities of Huntington disease can pose challenges for diagnosis. Let's take a look at its neuropsychiatric symptoms and the need for comprehensive treatment strategies.
The Cellist
"Tonight their eyes meet with the spirit of sacred music..."
Sleep-Related Eating Disorder: A Distressing But Treatable Complex Parasomnia
Discover the complexities of sleep-related eating disorder, its symptoms, triggers, and effective treatments for better sleep health.
Dysphoric Milk Ejection Reflex: What Is the Diagnosis?
Dysphoric milk ejection reflex (D-MER) causes brief emotional distress during breastfeeding, often misdiagnosed as postpartum depression, requiring better awareness and support.
Assessing and Treating PTSD in the Wake of Natural Disasters: Lessons From Katrina to Today
Hurricane Katrina's legacy highlights the urgent need for trauma-informed mental health care in disaster recovery, addressing PTSD and long-term emotional impacts.
FDA Approves KETARx for Management of Surgical Pain
PharmaTher's KETARx gains FDA approval, paving the way for innovative ketamine treatments in pain management and mental health disorders.